The phenomenon known as acquired activated protein C resistance
- 20 December 2001
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 115 (4) , 767-773
- https://doi.org/10.1046/j.1365-2141.2001.03203.x
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- End of the line for “third-generation-pill” controversy?The Lancet, 1997
- Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second‐ and third‐generation oral contraceptivesBritish Journal of Haematology, 1997
- Effect of activated protein C on thrombin generation and on the thrombin potential in plasma of normal and APC-resistant individualsBlood Coagulation & Fibrinolysis, 1997
- The influence of factor VIII on measurement of activated protein C resistanceBlood Coagulation & Fibrinolysis, 1996
- The factor V Leiden mutation may predispose women to severe preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1996
- Resistance to activated protein C in healthy women taking oral contraceptivesBritish Journal of Haematology, 1995
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Evaluation of oral anticoagulant therapy by measuring plasma prothrombin fragment 1 + 2Blood Coagulation & Fibrinolysis, 1993
- Increased Incidence of Deep Vein Thrombosis after Myocardial Infarction in Non-smokersBMJ, 1974
- A1, A2, B, AND O BLOOD-GROUPS, LEWIS BLOOD-GROUPS, AND SERUM TRIGLYCERIDE AND CHOLESTEROL CONCENTRATIONS IN PATIENTS WITH VENOUS THROMBOEMBOLIC DISEASEThe Lancet, 1972